{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:10:11Z","timestamp":1785845411666,"version":"3.56.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730084"],"award-info":[{"award-number":["81730084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jdermsci.2022.05.006","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:32:18Z","timestamp":1653093138000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Tiamulin inhibits TNF-\u03b1 and alleviates psoriasis-like dermatitis"],"prefix":"10.1016","volume":"107","author":[{"given":"Ruiyu","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongya","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10281","key":"10.1016\/j.jdermsci.2022.05.006_bib1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"Griffiths","year":"2021","journal-title":"J. Bark. Psoriasis Lancet"},{"key":"10.1016\/j.jdermsci.2022.05.006_bib2","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jdermsci.2022.05.006_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.057","article-title":"Psoriasis: which therapy for which patient: Psoriasis comorbidities and preferred systemic agents","volume":"80","author":"Kaushik","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"10.1016\/j.jdermsci.2022.05.006_bib4","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1172\/JCI28508","article-title":"The IL-23\/IL-17 axis in inflammation","volume":"116","author":"Iwakura","year":"2006","journal-title":"J. Clin. Invest"},{"issue":"5","key":"10.1016\/j.jdermsci.2022.05.006_bib5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1084\/jem.20031482","article-title":"Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha","volume":"199","author":"Boyman","year":"2004","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.jdermsci.2022.05.006_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cytogfr.2014.07.016","article-title":"TNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants - past, present and future","volume":"25","author":"Sedger","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.jdermsci.2022.05.006_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/physrev.00045.2017","article-title":"The TNF family of ligands and receptors: communication modules in the immune system and beyond","volume":"99","author":"Dostert","year":"2019","journal-title":"Physiol. Rev."},{"issue":"9494","key":"10.1016\/j.jdermsci.2022.05.006_bib8","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(05)67566-6","article-title":"Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial","volume":"366","author":"Reich","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jdermsci.2022.05.006_bib9","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/bjd.20413","article-title":"Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy study","volume":"185","author":"Gottlieb","year":"2021","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.jdermsci.2022.05.006_bib10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.pharep.2014.05.004","article-title":"TNF inhibitors - mechanisms of action, approved and off-label indications","volume":"66","author":"Cessak","year":"2014","journal-title":"Pharm. Rep."},{"issue":"5","key":"10.1016\/j.jdermsci.2022.05.006_bib11","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/ijc.31407","article-title":"Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions","volume":"143","author":"Calip","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.jdermsci.2022.05.006_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/rheumatology\/key241","article-title":"Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register","volume":"58","author":"Fagerli","year":"2019","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jdermsci.2022.05.006_bib13","first-page":"649","article-title":"Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA","volume":"37","author":"Atzeni","year":"2019","journal-title":"Clin. Exp. Rheuma"},{"key":"10.1016\/j.jdermsci.2022.05.006_bib14","doi-asserted-by":"crossref","first-page":"adv00648","DOI":"10.2340\/actadv.v102.175","article-title":"Global risk of bacterial skin infections and herpesviridae infections with ustekinumab, secukinumab, and tumour necrosis factor-alpha inhibitors: spontaneous reports of adverse drug reactions from the world health organization pharmacovigilance center","volume":"102","author":"Davidson","year":"2022","journal-title":"Acta Derm. Venereol."},{"issue":"1","key":"10.1016\/j.jdermsci.2022.05.006_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaad.2021.07.040","article-title":"Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial","volume":"86","author":"Stein Gold","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"10","key":"10.1016\/j.jdermsci.2022.05.006_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102902","article-title":"JAK inhibitors and psoriatic arthritis: a systematic review and meta-analysis","volume":"20","author":"Campanaro","year":"2021","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.jdermsci.2022.05.006_bib17","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a027110","article-title":"Pleuromutilins: potent drugs for resistant bugs-mode of action and resistance","volume":"7","author":"Paukner","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.jdermsci.2022.05.006_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaad.2021.06.869","article-title":"Tyrosine kinase 2 and Janus kinase3signal transducer and activator of transcription signaling and inhibition in plaque psoriasis","volume":"86","author":"Krueger","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"10.1016\/j.jdermsci.2022.05.006_bib19","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"issue":"14","key":"10.1016\/j.jdermsci.2022.05.006_bib20","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/ajhp\/zxab160","article-title":"National trends in prescription drug expenditures and projections for 2021","volume":"78","author":"Tichy","year":"2021","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"25","key":"10.1016\/j.jdermsci.2022.05.006_bib21","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.2174\/0929867322666150729115553","article-title":"Small Molecules as Anti-TNF Drugs","volume":"22","author":"Richmond","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"23","key":"10.1016\/j.jdermsci.2022.05.006_bib22","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1021\/jm990377j","article-title":"New alpha-substituted succinate-based hydroxamic acids as TNFalpha convertase inhibitors","volume":"42","author":"Barlaam","year":"1999","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.jdermsci.2022.05.006_bib23","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0022-3565(24)29455-6","article-title":"Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases","volume":"298","author":"Conway","year":"2001","journal-title":"J. Pharm. Exp. Ther."},{"issue":"5750","key":"10.1016\/j.jdermsci.2022.05.006_bib24","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1126\/science.1116304","article-title":"Small-molecule inhibition of TNF-alpha","volume":"310","author":"He","year":"2005","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.jdermsci.2022.05.006_bib25","doi-asserted-by":"crossref","first-page":"8146","DOI":"10.1021\/acs.jmedchem.0c00377","article-title":"Discovery of an orally active small-molecule tumor necrosis factor-\u03b1 inhibitor","volume":"63","author":"Sun","year":"2020","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.jdermsci.2022.05.006_bib26","doi-asserted-by":"crossref","first-page":"12457","DOI":"10.1074\/jbc.M113.521708","article-title":"A novel small-molecule tumor necrosis factor \u03b1 inhibitor attenuates inflammation in a hepatitis mouse model","volume":"289","author":"Ma","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.jdermsci.2022.05.006_bib27","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.apsb.2020.11.008","article-title":"Uptake and trafficking of different sized PLGA nanoparticles by dendritic cells in imiquimod-induced psoriasis-like mice model","volume":"11","author":"Lin","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.jdermsci.2022.05.006_bib28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jdermsci.2020.05.013","article-title":"Facile skin targeting of a thalidomide analog containing benzyl chloride moiety alleviates experimental psoriasis via the suppression of MAPK\/NF-\u03baB\/AP-1 phosphorylation in keratinocytes","volume":"99","author":"Tang","year":"2020","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2022.05.006_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2021.12.036","article-title":"TNFR2 depletion reduces psoriatic inflammation in mice by downregulating specific dendritic cell populations in lymph nodes and inhibiting IL-23\/IL-17 pathways","author":"Chandrasekharan","year":"2022","journal-title":"J. Investig. Dermatol."},{"issue":"9","key":"10.1016\/j.jdermsci.2022.05.006_bib30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.7164\/antibiotics.29.923","article-title":"New pleuromutilin derivatives with enhanced antimicrobial activity.II.Structure-activity correlations","volume":"29","author":"Egger","year":"1976","journal-title":"J. Antibiot."},{"key":"10.1016\/j.jdermsci.2022.05.006_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1749-6632.2011.06219.x","article-title":"Are pleuromutilin antibiotics finally fit for human use?","volume":"1241","author":"Novak","year":"2011","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"4","key":"10.1016\/j.jdermsci.2022.05.006_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02388-17","article-title":"Unraveling the metabolic routes of retapamulin: insights into drug development of pleuromutilins","volume":"62","author":"Sun","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.jdermsci.2022.05.006_bib33","doi-asserted-by":"crossref","first-page":"Jc22","DOI":"10.7326\/ACPJ202002180-022","article-title":"In community-acquired bacterial pneumonia, lefamulin was noninferior to moxifloxacin at 96h after the first dose","volume":"172","author":"Powell","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jdermsci.2022.05.006_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.704197","article-title":"Therapeutic applications of terpenes on inflammatory diseases","volume":"12","author":"Del Prado-Audelo","year":"2021","journal-title":"Front. Pharm."},{"issue":"7\u20138","key":"10.1016\/j.jdermsci.2022.05.006_bib35","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.intimp.2009.02.018","article-title":"Valnemulin downregulates nitric oxide, prostaglandin E2, and cytokine production via inhibition of NF-kappaB and MAPK activity","volume":"9","author":"Zhang","year":"2009","journal-title":"Int. Immunopharmacol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181122001268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181122001268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:22:45Z","timestamp":1778764965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181122001268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0923181122001268"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2022.05.006","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tiamulin inhibits TNF-\u03b1 and alleviates psoriasis-like dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2022.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}